Trial intelligence / Profile preview

Postoperative dexmedetomidine sedation versus propofol for delirium prevention after CABG

ChiCTR2000033436Phase 4Not yet recruiting

Sponsor
Fuwai Hospital
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine and propofol in delirium (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Delirium incidence. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

dexmedetomidinepropofol
03

Conditions

delirium

Beyond the preview

Go deeper on ChiCTR2000033436.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000033436.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call